Abstract
P16‐86: Tolerability and safety of nintedanib for idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung diseases
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have